The best biotech stocks right now, ranked.
We score 536 US-listed biotech stocks, re-ranked every trading day. These 25 rank highest on the full factor model right now. Every US-listed stock Twelve Data files under Biotechnology.
Every score is a percentile across the whole US universe we cover — a 92 beats 92% of it. How the model was built and blind-tested is on the methodology page; what each factor means is on the factor glossary.
| Ticker | Company | Mkt cap | Rank | 1w rank Δ | Revisions | Value | Momentum | Quality | Accruals | Issuance | Growth | Volatility | Size |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. Biotechnology | $16.8B | 99.7 | 0.0 | 85.2 | 99.4 | 93.4 | 98.1 | 82.4 | 94.9 | 74.2 | 98.7 | 10.9 | |
OmniAb, Inc. Biotechnology | $702.2M | 99.3 | +2.8 | 95.1 | 72.7 | 99.0 | 64.9 | 94.0 | 66.1 | 95.3 | 35.1 | 47.5 | |
Halozyme Therapeutics, Inc. Biotechnology | $14.0B | 97.8 | −0.4 | 89.0 | 98.6 | 96.1 | 98.7 | 67.6 | 45.7 | 68.7 | 97.5 | 12.3 | |
Aurinia Pharmaceuticals, Inc. Biotechnology | $2.2B | 97.8 | +0.2 | 77.8 | 99.3 | 83.8 | 96.8 | 22.1 | 87.6 | 82.0 | 96.1 | 33.4 | |
Royalty Pharma Plc Biotechnology | $38.9B | 97.6 | +11.4 | 88.6 | 85.1 | 99.4 | 73.0 | 74.0 | 77.8 | 70.3 | 99.4 | 5.9 | |
Protagonist Therapeutics, Inc. Biotechnology | $8.6B | 97.3 | −0.3 | 81.3 | 93.9 | 94.7 | 83.3 | 68.9 | 54.7 | 82.8 | 98.1 | 16.2 | |
Vir Biotechnology, Inc. Biotechnology | $1.9B | 97.0 | +5.8 | 83.9 | 92.5 | 92.5 | 90.6 | 42.1 | 50.9 | 98.8 | 65.2 | 35.6 | |
MediciNova, Inc. Biotechnology | $71.3M | 96.9 | +0.3 | 81.1 | 62.5 | 62.1 | 59.2 | 70.7 | 77.1 | 87.6 | 87.9 | 76.2 | |
Vericel Corp. Biotechnology | $2.6B | 96.5 | +2.8 | 84.9 | 60.6 | 85.3 | 96.4 | 62.6 | 74.0 | 79.1 | 82.4 | 31.1 | |
Zevra Therapeutics, Inc. Biotechnology | $618.2M | 96.4 | −0.8 | 82.5 | 98.9 | 64.8 | 99.3 | 22.7 | 74.8 | 78.5 | 90.6 | 49.2 | |
Regeneron Pharmaceuticals, Inc. Biotechnology | $94.9B | 96.3 | +2.4 | 96.3 | 95.1 | 89.7 | 82.9 | 37.2 | 77.3 | 78.7 | 96.4 | 2.7 | |
Fate Therapeutics, Inc. Biotechnology | $215.1M | 96.0 | −0.4 | 81.1 | 61.1 | 81.8 | 65.1 | 81.3 | 72.0 | 94.8 | 22.6 | 64.8 | |
Jazz Pharmaceuticals Plc Biotechnology | $14.3B | 95.9 | +0.1 | 64.6 | 99.5 | 93.5 | 82.9 | 89.9 | 34.1 | 94.0 | 99.8 | 12.1 | |
AnaptysBio, Inc. Biotechnology | $1.3B | 94.1 | −0.8 | 70.6 | 98.3 | 78.4 | 72.1 | 26.0 | 79.6 | 94.6 | 90.3 | 39.7 | |
Iovance Biotherapeutics, Inc. Biotechnology | $3.5B | 93.9 | +1.5 | 95.6 | 92.3 | 89.9 | 97.1 | 40.7 | 45.8 | 88.3 | 27.5 | 27.5 | |
ImmuCell Corp. Biotechnology | $90.4M | 93.3 | −0.3 | 25.0 | 75.4 | 90.5 | 95.8 | 96.3 | 80.0 | 40.5 | 88.5 | 74.0 | |
Fortrea Holdings, Inc. Biotechnology | $1.9B | 93.0 | +0.8 | 66.5 | 83.6 | 92.5 | 59.4 | 92.0 | 72.5 | 91.9 | 8.9 | 34.9 | |
Nurix Therapeutics, Inc. Biotechnology | $1.6B | 92.8 | −1.3 | 78.1 | 98.5 | 89.6 | 98.1 | 49.0 | 18.6 | 99.4 | 43.8 | 37.3 | |
Xencor, Inc. Biotechnology | $2.5B | 92.4 | +7.0 | 77.6 | 76.5 | 99.6 | 79.3 | 51.6 | 73.0 | 57.7 | 83.1 | 31.7 | |
Arbutus Biopharma Corp. Biotechnology | $722.8M | 92.4 | −1.7 | 77.5 | 97.0 | 52.0 | 97.2 | 18.6 | 58.4 | 99.2 | 82.9 | 47.2 | |
Enanta Pharmaceuticals, Inc. Biotechnology | $293.6M | 92.3 | +6.7 | 46.3 | 78.5 | 61.0 | 89.4 | 73.6 | 67.6 | 93.8 | 65.8 | 60.1 | |
Precigen, Inc. Biotechnology | $1.5B | 92.2 | +15.5 | 92.1 | 96.7 | 81.4 | 85.4 | 12.2 | 38.8 | 98.9 | 71.6 | 38.2 | |
Omeros Corp. Biotechnology | $1.2B | 92.1 | +0.2 | 99.0 | 68.5 | 95.4 | 77.5 | 32.9 | 77.2 | 74.5 | 20.0 | 41.0 | |
Bio-Techne Corp. Biotechnology | $11.3B | 91.9 | +0.4 | 59.3 | 80.9 | 92.6 | 76.8 | 69.1 | 90.2 | 67.8 | 88.1 | 13.8 | |
Septerna, Inc. Biotechnology | $2.1B | 91.5 | +4.3 | 79.0 | 75.8 | 93.9 | 60.6 | 90.4 | 42.2 | 89.6 | 33.2 | 33.7 |
Today’s snapshot only — the list rotates as the scores move. Click any ticker for its full page: rank against every factor, analyst price targets, financials and news.
What these biotech stocks look like up close.
Figures for the 25 listed names, from the same data behind their stock pages.
21 of the 24 names with analyst coverage this month carry a Buy-or-better majority.
Cheapest on trailing P/E: ABUS at 5.1×, NRIX at 6.1× and AUPH at 7.1×.
Highest forward dividend yields: RPRX at 1.4%, TECH at 0.4% and REGN at 0.4%.
Where we've written the stock up.
An analyst-style read on the business behind the score — published on the stock page.
This page is one list. Monday covers the whole market.
The names above rotate as the scores move. The Radar is how you hear what changed.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Questions people ask about biotech stocks.
- What are the best biotech stocks right now?
- As at 5 Nov 2026, the top-ranked biotech stocks on Ticker Nerd's systematic factor model are Exelixis, Inc. (EXEL), OmniAb, Inc. (OABI), Halozyme Therapeutics, Inc. (HALO). The full top 25 is the table on this page, re-ranked every trading day. A rank is general information, not personal advice.
- How does Ticker Nerd pick the best biotech stocks?
- Nobody picks them. A factor model scores roughly 4,600 US stocks every trading day on families like value, momentum, quality and growth, and this page is one fixed cut of that ranking. The research process behind the model — point-in-time data from 2005, locked test windows, logged rejections — is published on the methodology page.
- Are biotech stocks a good investment?
- That depends on the price paid and on your circumstances — this page is general information, not advice. What the data says as at 5 Nov 2026: of the 24 listed names with analyst coverage this month, 21 carry a Buy-or-better majority, and every rank above is a percentile across roughly 4,600 US stocks.
The same model, other cuts.
Every list reads the one ranking — the stock screener index has the complete set.